FindTrial
Sign In

Allisartan Isoproxil

DRUG5 trials

Sponsors

Yan Li, XueQing Yu, Shanghai Jiao Tong University School of Medicine, Guangdong Provincial People's Hospital, Shenzhen Salubris Pharmaceuticals Co., Ltd.

Conditions

Adverse EventAtrial FibrillationBlood PressureCardiovascular Risk FactorDiabetes Mellitus, Type 2Essential HypertensionHypertensionMasked Hypertension

Phase 3

To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil
CompletedNCT06500689
Shenzhen Salubris Pharmaceuticals Co., Ltd.Essential Hypertension
Start: 2021-12-30End: 2024-05-24Updated: 2024-07-15

Phase 4

Antihypertensive Treatment in Masked Hypertension
CompletedNCT02893358
Yan LiMasked Hypertension
Start: 2017-02-14End: 2022-03-30Updated: 2025-01-06
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
RecruitingNCT03264352
XueQing YuAdverse Event, Blood Pressure, Cardiovascular Risk Factor +2
Start: 2018-02-01End: 2025-09-30Target: 11414Updated: 2025-03-12
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Active, not recruitingNCT04111419
Shanghai Jiao Tong University School of MedicineAtrial Fibrillation, Hypertension
Start: 2020-07-01End: 2026-12-31Target: 1200Updated: 2025-08-13
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy
WithdrawnNCT04978649
Guangdong Provincial People's HospitalBlood Pressure, Diabetes Mellitus, Type 2
Start: 2021-09-01End: 2028-07-31Updated: 2022-08-26

Related Papers

Efficacy of antihypertensive treatment for target organ protection in patients with masked hypertension (ANTI-MASK): a multicentre, double-blind, placebo-controlled trial.
2024-07-189 citations
URBAN-RURAL DISPARITIES IN THE PREVALENCE AND MANAGEMENT OF ATRIAL FIBRILLATION IN ELDERLY CHINESE
Journal of Hypertension2023-06-01
S-46-3: ANTIHYPERTENSIVE TREATMENT IN MASKED HYPERTENSION FOR TARGET ORGAN PROTECTION (ANTI-MASK): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Journal of Hypertension2023-01-01
Antihypertensive treatment in masked hypertension for target organ protection (ANTI-MASK): a randomized, double-blind, placebo-controlled trial
Blood Pressure Monitoring2022-11-255 citations
ANTIHYPERTENSIVE TREATMENT IN MASKED HYPERTENSION FOR TARGET ORGAN PROTECTION (ANTI-MASK): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Journal of Hypertension2022-06-011 citations
Rationale and Design of a Randomized Controlled Trial on Intensive Management of Blood PRESSure and Cholesterol in Elderly Chinese with Hypertension and Atrial FibrillatION (IMPRESSION)
Cardiology Discovery2021-07-084 citations